
Global Glucagon Market By Route of Administration(Injectable, Inhalation), By Application(Hypoglycemia, Diagnostic Aid), By Distribution Channel(Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies), By Region And Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, And Forecast 2024-2033
-
45629
-
May 2024
-
300
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Quick Navigation
Report Overview
The Global Glucagon Market was valued at USD 294.0 million in 2023. It is expected to reach USD 553.3 million by 2033, with a CAGR of 6.7% during the forecast period from 2024 to 2033.
The Glucagon Market pertains to the segment within the pharmaceutical industry focused on the production, distribution, and utilization of glucagon-based products. Glucagon, a hormone crucial in regulating blood sugar levels, finds application primarily in emergency medical situations such as severe hypoglycemia and diabetic emergencies.
Market analysis of the Glucagon Market encompasses factors like technological advancements, regulatory frameworks, competitive landscape, and emerging therapeutic indications. As demand for diabetic care continues to surge globally, propelled by the rising prevalence of diabetes and increasing awareness about advanced treatment options, the Glucagon Market presents substantial growth opportunities for stakeholders across the pharmaceutical value chain.
The glucagon market, a vital component within the realm of diabetes management, has undergone nuanced shifts reflective of evolving patient demographics and treatment paradigms. Amidst this landscape, our analysis reveals intriguing trends underscoring both challenges and opportunities within the market.
Over the period from 2013 to 2017, our data elucidates a notable divergence in quarterly glucagon prescription rates among distinct patient cohorts. While the overall quarterly rates of glucagon prescriptions among U.S. adults with diabetes and kidney failure undergoing replacement therapy exhibited a modest decline from 1.73% to 1.46%, this trend masks distinct patterns within type 1 and type 2 diabetes populations.
Remarkably, despite stability among type 1 diabetes patients, rates decreased significantly among type 2 diabetes patients, signaling a nuanced response to therapeutic interventions or shifts in treatment guidelines.
Furthermore, the ascendancy of novel therapeutic agents, exemplified by the meteoric rise of Ozempic (semaglutide), underscores a pivotal inflection point within the glucagon market. The unprecedented surge in Ozempic users, catapulting it to the forefront as the most frequently utilized GLP-1 agonist, reflects both shifting treatment preferences and the compelling efficacy profile of newer entrants.
These insights illuminate a dynamic landscape within the glucagon market, punctuated by evolving therapeutic paradigms and shifting patient preferences. Amidst these developments, stakeholders must navigate this intricate terrain with agility, leveraging data-driven strategies to capitalize on emerging opportunities and mitigate potential challenges.
Key Takeaways
- Market Growth: The Global Glucagon Market was valued at USD 294.0 million in 2023. It is expected to reach USD 553.3 million by 2033, with a CAGR of 6.7% during the forecast period from 2024 to 2033.
- By Route of Administration: The injectable route dominates the glucagon market with a commanding 60% share.
- By Application Analysis: Hypoglycemia application holds a significant market share, commanding 45% dominance.
- By Distribution Channel: Drug stores & retail pharmacies lead in distribution, dominating with a 60% share.
- Regional Dominance: In North America, the Glucagon market commands a significant 45% share.
- Growth Opportunity: In 2023, the global Glucagon Market experienced growth driven by innovative formulations for easier administration and the expansion of healthcare infrastructure in emerging markets.
Driving factors
Advancements in Glucagon Delivery Methods Driving Market Expansion
The glucagon market is experiencing significant growth propelled by advancements in delivery methods, notably the emergence of nasal sprays. Nasal sprays offer a non-invasive, user-friendly alternative to traditional injection methods, addressing patient preferences for painless administration and convenience. As a result, the adoption of nasal sprays is escalating, driving market expansion.
According to recent statistics, the global nasal delivery devices market, which encompasses nasal sprays, is projected to witness a compound annual growth rate (CAGR) of over 6% during the forecast period. This growth is attributed to the increasing prevalence of diabetes and hypoglycemia, coupled with rising demand for efficient and user-friendly glucagon delivery solutions.
Strategic Alliances and R&D Investments Fueling Market Growth
Key players in the glucagon market are actively engaging in strategic alliances and ramping up research and development (R&D) investments to capitalize on emerging opportunities. Collaborations between pharmaceutical companies and technology firms are facilitating the development of innovative glucagon delivery systems and enhancing product portfolios.
These strategic initiatives are underpinned by substantial investments in R&D aimed at advancing drug formulations, optimizing delivery mechanisms, and improving therapeutic outcomes. Notably, recent market analysis indicates a surge in R&D spending by major industry players, with a notable portion allocated to glucagon-related research.
Favorable Regulatory Frameworks and Reimbursement Policies Stimulating Market Expansion
Favorable regulatory frameworks and reimbursement policies are playing a pivotal role in stimulating market expansion for glucagon products. Regulatory agencies are streamlining approval processes for novel glucagon formulations and delivery devices, expediting market entry and commercialization.
Moreover, robust reimbursement policies are enhancing patient access to glucagon therapies, driving adoption rates and market penetration. The implementation of reimbursement schemes and insurance coverage for glucagon products is alleviating financial barriers for patients, thereby fostering market growth.
Restraining Factors
Ignorance Hinders Glucagon Market Growth
The glucagon market faces significant challenges due to a lack of awareness about the importance of maintaining normal blood sugar levels. Ignorance among the general population about the risks associated with hypoglycemia and the need for glucagon medication contributes to a limited market for these medicines. Despite the growing prevalence of diabetes and related conditions, a substantial portion of the population remains unaware of the critical role glucagon plays in managing hypoglycemic episodes.
According to recent surveys, a significant percentage of individuals with diabetes or prediabetes lack adequate knowledge about hypoglycemia and its management, including the use of glucagon. This lack of awareness translates into low demand for glucagon products, hindering market growth.
Underdiagnosis of Diabetes Dampens Demand for Glucagon Products
The underdiagnosis of diabetes poses a notable constraint on the growth of the glucagon market. A considerable portion of the diabetic population remains undiagnosed, resulting in lower demand for glucagon products. The failure to identify individuals with diabetes deprives them of essential treatments and preventive measures, including glucagon therapy.
Recent epidemiological studies indicate that a significant proportion of diabetes cases worldwide remain undiagnosed, particularly in low- and middle-income countries where healthcare infrastructure and access to diagnostic services are limited. This underdiagnosis not only compromises patient outcomes but also curtails the market potential for glucagon products.
By Route of Administration Analysis
Injectable route of administration dominates the glucagon market with a commanding share of 60%.
In 2023, Injectable held a dominant market position in the By Route of Administration segment of the Glucagon Market, capturing more than a 60% share. This remarkable dominance can be attributed to the inherent advantages of injectable formulations, including rapid onset of action and ease of administration, particularly in emergencies such as severe hypoglycemia. Injectable glucagon products offer healthcare professionals a reliable and efficient means of raising blood sugar levels quickly, thereby averting potentially life-threatening complications associated with hypoglycemia.
The growing prevalence of diabetes, coupled with the increasing awareness regarding the importance of managing hypoglycemia effectively, has significantly propelled the demand for injectable glucagon formulations. Moreover, advancements in drug delivery technologies have further enhanced the usability and efficacy of injectable products, thereby reinforcing their position as the preferred choice among healthcare practitioners and patients alike.
Looking ahead, the Injectable segment is poised for continued growth, driven by ongoing research and development initiatives aimed at improving formulation stability, enhancing ease of administration, and prolonging shelf life. Additionally, strategic collaborations between pharmaceutical companies and healthcare organizations are anticipated to facilitate the introduction of innovative injectable glucagon formulations into the market, catering to the evolving needs of patients and healthcare professionals.
As the cornerstone of the Glucagon Market, the Injectable segment is projected to maintain its dominant position in the coming years, offering promising opportunities for market players to capitalize on the growing demand for effective hypoglycemia management solutions.
By Application Analysis
Hypoglycemia application holds a significant market share, commanding 45% of the total.
In 2023, Hypoglycemia held a dominant market position in the By Application segment of the Glucagon Market, capturing more than a 45% share. This substantial market share underscores the critical role of glucagon in managing hypoglycemic episodes, both in clinical settings and for self-administration by patients with diabetes. As a rapid-acting hormone, glucagon effectively counteracts hypoglycemia by stimulating the liver to release stored glucose into the bloodstream, thereby restoring blood sugar levels to within a normal range.
The Hypoglycemia segment encompasses a wide range of applications, with Diagnostic Aid emerging as a prominent use case. Glucagon serves as an invaluable tool for diagnosing and confirming hypoglycemia, enabling healthcare professionals to promptly identify and address this potentially life-threatening condition. By facilitating accurate and timely diagnosis, glucagon plays a pivotal role in guiding appropriate treatment interventions and ensuring optimal patient outcomes.
The growing prevalence of diabetes, coupled with the increasing recognition of hypoglycemia as a significant complication of diabetes management, has fueled the demand for glucagon as a diagnostic aid. Moreover, advancements in glucometer technology and the integration of glucagon rescue kits into diabetes management protocols have further bolstered the adoption of glucagon for hypoglycemia diagnosis.
Looking ahead, the Hypoglycemia segment is poised for sustained growth, driven by the continued emphasis on proactive hypoglycemia management strategies and the expanding application of glucagon in various healthcare settings. As stakeholders continue to prioritize patient safety and optimize diabetes care pathways, the Hypoglycemia segment is expected to remain at the forefront of the Glucagon Market, presenting lucrative opportunities for market participants to capitalize on the growing demand for hypoglycemia management solutions.
By Distribution Channel Analysis
Drug stores & retail pharmacies are the primary distribution channels, accounting for a dominant 60%.
In 2023, Drug Stores & Retail Pharmacies held a dominant market position in the By Distribution Channel segment of the Glucagon Market, capturing more than a 60% share. This significant market dominance underscores the widespread accessibility and convenience offered by drug stores and retail pharmacies in distributing glucagon products to consumers.
With their extensive network of outlets and established distribution channels, drug stores and retail pharmacies play a pivotal role in ensuring timely access to essential medications, including glucagon, for individuals managing diabetes and related conditions.
The appeal of drug stores and retail pharmacies as preferred distribution channels for glucagon products lies in their proximity to consumers and their ability to provide personalized guidance and support for patients requiring emergency hypoglycemia treatment.
Moreover, the availability of over-the-counter (OTC) glucagon formulations in these establishments enhances convenience for individuals seeking immediate access to emergency hypoglycemia management solutions without the need for a prescription.
The dominance of Drug Stores & Retail Pharmacies in the Glucagon Market is further reinforced by the increasing emphasis on self-care and patient empowerment in diabetes management. As individuals take a more proactive approach to their health and seek greater autonomy in managing their condition, the convenience and accessibility offered by drug stores and retail pharmacies become increasingly valuable.
Looking ahead, Drug Stores & Retail Pharmacies are poised to maintain their stronghold in the Glucagon Market, supported by evolving consumer preferences, expanding retail footprints, and ongoing efforts to enhance the availability and affordability of glucagon products. As stakeholders continue to prioritize patient-centric care delivery models, drug stores and retail pharmacies will remain integral to ensuring widespread access to vital diabetes management medications, including glucagon.
Key Market Segments
By Route of Administration
- Injectable
- Inhalation
By Application
- Hypoglycemia
- Diagnostic Aid
By Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
Growth Opportunity
Development of Novel Formulations for Convenient Administration
In 2023, the global Glucagon Market witnessed a significant growth opportunity spurred by the development of novel formulations tailored for convenient administration. As medical technology continues to advance, pharmaceutical companies have innovated new delivery methods for glucagon, catering to the evolving needs of patients and healthcare providers.
These formulations offer enhanced ease of use, ensuring swift and effective administration during critical situations such as severe hypoglycemia episodes. By addressing the challenges associated with traditional glucagon delivery, such as complex reconstitution processes, these innovations are poised to expand the market reach and accessibility of glucagon products.
Expansion of Healthcare Infrastructure in Emerging Markets
Furthermore, the expansion of healthcare infrastructure in emerging markets has presented a promising avenue for growth in the global Glucagon Market. As economies develop and healthcare spending increases, there is a growing demand for essential pharmaceuticals, including glucagon, to address the rising prevalence of diabetes and related complications.
Governments and private stakeholders in emerging economies are investing in healthcare infrastructure, bolstering access to essential medicines and medical services. This trend not only enhances the availability of glucagon products but also fosters greater awareness and adoption of diabetes management strategies, driving market expansion.
Latest Trends
Development of Glucagon Rescue Kits for Home Use
In 2023, the global Glucagon Market witnessed a notable trend with the development of glucagon rescue kits tailored for home use. Traditionally, glucagon has been administered by healthcare professionals or caregivers in emergency settings. However, advancements in technology and formulation have enabled the creation of user-friendly glucagon kits designed for self-administration by patients or their family members.
These kits typically feature pre-filled syringes or auto-injectors, along with simplified instructions for use. This trend reflects a shift towards empowering individuals with diabetes to manage severe hypoglycemia episodes independently, enhancing their autonomy and quality of life.
Integration of Glucagon in Closed-Loop Insulin Delivery Systems
Another significant trend in the global Glucagon Market in 2023 was the integration of glucagon in closed-loop insulin delivery systems. Closed-loop systems, also known as artificial pancreas systems, automate insulin delivery based on real-time glucose monitoring, providing precise control of blood sugar levels.
The integration of glucagon alongside insulin in these systems aims to mitigate the risk of hypoglycemia by administering glucagon when glucose levels fall too low. This innovation represents a paradigm shift in diabetes management, offering a comprehensive solution for optimizing glycemic control while minimizing the burden of hypoglycemic events.
Regional Analysis
In North America, the glucagon market holds a dominant share, accounting for approximately 45%.
In the global glucagon market, North America emerges as a dominant force, commanding a significant share of approximately 45%. This region's prominence is attributed to several factors, including the high prevalence of diabetes and increasing awareness regarding hypoglycemia management. With a robust healthcare infrastructure and substantial investments in research and development, North America remains at the forefront of glucagon adoption and innovation.
Europe stands as another key player in the glucagon market, characterized by a growing diabetic population and rising demand for advanced therapeutics. The region benefits from favorable government initiatives promoting diabetes management and healthcare accessibility.
Additionally, the presence of prominent pharmaceutical companies and research institutions fosters the development of novel glucagon formulations and delivery methods. Europe accounts for a substantial portion of the global market share, reflecting its significant contribution to industry growth.
In the Asia Pacific region, rapid urbanization, changing lifestyles, and increasing healthcare expenditure drive the demand for glucagon products. Countries like China and India witness a surge in diabetes prevalence, fueling market expansion. Moreover, heightened awareness about diabetes management and advancements in healthcare infrastructure propel the adoption of glucagon therapies across the region. Asia Pacific emerges as a lucrative market opportunity with considerable growth potential in the forecast period.
The Middle East & Africa and Latin America regions exhibit a growing interest in glucagon therapies, albeit at a slower pace compared to their counterparts. Limited healthcare infrastructure and economic constraints pose challenges to market penetration.
However, rising diabetes awareness initiatives and improving access to healthcare services contribute to incremental growth in these regions. As the global market evolves, strategic investments and partnerships are anticipated to drive market penetration and enhance product accessibility in these regions.
Key Regions and Countries
North America
- The US
- Canada
- Rest of North America
Europe
- Germany
- France
- The UK
- Spain
- Netherlands
- Russia
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- Singapore
- Thailand
- South Korea
- Vietnam
- India
- New Zealand
- Rest of Asia Pacific
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East & Africa
Key Players Analysis
In 2023, the global glucagon market witnessed dynamic competition among key players, including Novo Nordisk A/S, Fresenius SE & Co. KGaA, Amphastar Pharmaceuticals, Inc., Xeris Biopharma Holdings, Inc., ILS Inc., United Biotech (P) Limited, Zealand Pharma A/S, and Taj Pharmaceuticals Limited. Each of these companies played a pivotal role in shaping the market landscape, offering innovative products and strategic initiatives to address the evolving needs of healthcare providers and patients.
Novo Nordisk A/S, a prominent player based in Denmark, continued to maintain its stronghold in the glucagon market through its extensive product portfolio and strong global presence. The company's commitment to research and development, coupled with its focus on technological advancements, positioned it as a frontrunner in delivering effective glucagon therapies.
Meanwhile, Fresenius SE & Co. KGaA from Germany demonstrated notable growth, leveraging its diversified healthcare portfolio and robust distribution network to expand its market reach. Amphastar Pharmaceuticals, Inc., based in the United States, showcased resilience and agility in responding to market dynamics, with a focus on product innovation and strategic partnerships.
Xeris Biopharma Holdings, Inc. emerged as a key innovator, particularly in the field of ready-to-use glucagon formulations, catering to the needs of patients with diabetes. Additionally, companies such as ILS Inc., United Biotech (P) Limited, Zealand Pharma A/S, and Taj Pharmaceuticals Limited contributed to the market's competitiveness through their regional expertise, product differentiation strategies, and commitment to quality healthcare solutions.
Market Key Players
- Novo Nordisk A/S (Denmark)
- Fresenius SE & Co. KGaA (Germany)
- Amphastar Pharmaceuticals, Inc. (U.S.)
- Xeris Biopharma Holdings, Inc. (U.S.)
- ILS Inc. (Japan)
- United Biotech (P) Limited (India)
- Zealand Pharma A/S (Denmark)
- Taj Pharmaceuticals Limited (India)
Recent Development
- In January 2024, Bain & Company's report revealed $60B in global healthcare PE deals in 2023. Focus on biopharma, AI, GLP-1s, and India as a key investment hub. HCIT remains attractive amidst macro challenges.
- In February 2024, NTNU and St. Olavs Hospital developed MicroGlucagon, enhancing insulin therapy for type 1 diabetics. It accelerates insulin absorption, potentially reducing low blood sugar risks, and promising improved management.
Report Scope
Report Features Description Market Value (2023) USD 294.0 Million Forecast Revenue (2033) USD 553.3 Million CAGR (2024-2032) 6.7% Base Year for Estimation 2023 Historic Period 2016-2023 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Route of Administration(Injectable, Inhalation), By Application(Hypoglycemia, Diagnostic Aid), By Distribution Channel(Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) Regional Analysis North America - The US, Canada, Rest of North America, Europe - Germany, France, The UK, Spain, Italy, Russia, Netherlands, Rest of Europe, Asia-Pacific - China, Japan, South Korea, India, New Zealand, Singapore, Thailand, Vietnam, Rest of Asia Pacific, Latin America - Brazil, Mexico, Rest of Latin America, Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa Competitive Landscape Novo Nordisk A/S (Denmark), Fresenius SE & Co. KGaA (Germany), Amphastar Pharmaceuticals, Inc. (U.S.), Xeris Biopharma Holdings, Inc. (U.S.), ILS Inc. (Japan), United Biotech (P) Limited (India), Zealand Pharma A/S (Denmark), Taj Pharmaceuticals Limited (India) Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) -
- 1. Executive Summary
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 1.4. Key Analysis
- 1.5. Key Findings by Major Segments
- 1.6. Top strategies by Major Players
- 2. Global Glucagon Market Overview
- 2.1. Glucagon Market Dynamics
- 2.1.1. Drivers
- 2.1.2. Opportunities
- 2.1.3. Restraints
- 2.1.4. Challenges
- 2.2. Macro-economic Factors
- 2.3. Regulatory Framework
- 2.4. Market Investment Feasibility Index
- 2.5. PEST Analysis
- 2.6. PORTER’S Five Force Analysis
- 2.7. Drivers & Restraints Impact Analysis
- 2.8. Industry Chain Analysis
- 2.9. Cost Structure Analysis
- 2.10. Marketing Strategy
- 2.11. Russia-Ukraine War Impact Analysis
- 2.12. Opportunity Map Analysis
- 2.13. Market Competition Scenario Analysis
- 2.14. Product Life Cycle Analysis
- 2.15. Opportunity Orbits
- 2.16. Manufacturer Intensity Map
- 2.17. Major Companies sales by Value & Volume
- 2.1. Glucagon Market Dynamics
- 3. Global Glucagon Market Analysis, Opportunity and Forecast, 2016-2032
- 3.1. Global Glucagon Market Analysis, 2016-2021
- 3.2. Global Glucagon Market Opportunity and Forecast, 2023-2032
- 3.3. Global Glucagon Market Analysis, Opportunity and Forecast, By By Route of Administration, 2016-2032
- 3.3.1. Global Glucagon Market Analysis by By Route of Administration: Introduction
- 3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Route of Administration, 2016-2032
- 3.3.3. Injectable
- 3.3.4. Inhalation
- 3.4. Global Glucagon Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 3.4.1. Global Glucagon Market Analysis by By Application: Introduction
- 3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 3.4.3. Hypoglycemia
- 3.4.4. Diagnostic Aid
- 3.5. Global Glucagon Market Analysis, Opportunity and Forecast, By By Distribution Channel, 2016-2032
- 3.5.1. Global Glucagon Market Analysis by By Distribution Channel: Introduction
- 3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Distribution Channel, 2016-2032
- 3.5.3. Hospital Pharmacies
- 3.5.4. Drug Stores & Retail Pharmacies
- 3.5.5. Online Pharmacies
- 4. North America Glucagon Market Analysis, Opportunity and Forecast, 2016-2032
- 4.1. North America Glucagon Market Analysis, 2016-2021
- 4.2. North America Glucagon Market Opportunity and Forecast, 2023-2032
- 4.3. North America Glucagon Market Analysis, Opportunity and Forecast, By By Route of Administration, 2016-2032
- 4.3.1. North America Glucagon Market Analysis by By Route of Administration: Introduction
- 4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Route of Administration, 2016-2032
- 4.3.3. Injectable
- 4.3.4. Inhalation
- 4.4. North America Glucagon Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 4.4.1. North America Glucagon Market Analysis by By Application: Introduction
- 4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 4.4.3. Hypoglycemia
- 4.4.4. Diagnostic Aid
- 4.5. North America Glucagon Market Analysis, Opportunity and Forecast, By By Distribution Channel, 2016-2032
- 4.5.1. North America Glucagon Market Analysis by By Distribution Channel: Introduction
- 4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Distribution Channel, 2016-2032
- 4.5.3. Hospital Pharmacies
- 4.5.4. Drug Stores & Retail Pharmacies
- 4.5.5. Online Pharmacies
- 4.6. North America Glucagon Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 4.6.1. North America Glucagon Market Analysis by Country : Introduction
- 4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 4.6.2.1. The US
- 4.6.2.2. Canada
- 4.6.2.3. Mexico
- 5. Western Europe Glucagon Market Analysis, Opportunity and Forecast, 2016-2032
- 5.1. Western Europe Glucagon Market Analysis, 2016-2021
- 5.2. Western Europe Glucagon Market Opportunity and Forecast, 2023-2032
- 5.3. Western Europe Glucagon Market Analysis, Opportunity and Forecast, By By Route of Administration, 2016-2032
- 5.3.1. Western Europe Glucagon Market Analysis by By Route of Administration: Introduction
- 5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Route of Administration, 2016-2032
- 5.3.3. Injectable
- 5.3.4. Inhalation
- 5.4. Western Europe Glucagon Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 5.4.1. Western Europe Glucagon Market Analysis by By Application: Introduction
- 5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 5.4.3. Hypoglycemia
- 5.4.4. Diagnostic Aid
- 5.5. Western Europe Glucagon Market Analysis, Opportunity and Forecast, By By Distribution Channel, 2016-2032
- 5.5.1. Western Europe Glucagon Market Analysis by By Distribution Channel: Introduction
- 5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Distribution Channel, 2016-2032
- 5.5.3. Hospital Pharmacies
- 5.5.4. Drug Stores & Retail Pharmacies
- 5.5.5. Online Pharmacies
- 5.6. Western Europe Glucagon Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 5.6.1. Western Europe Glucagon Market Analysis by Country : Introduction
- 5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 5.6.2.1. Germany
- 5.6.2.2. France
- 5.6.2.3. The UK
- 5.6.2.4. Spain
- 5.6.2.5. Italy
- 5.6.2.6. Portugal
- 5.6.2.7. Ireland
- 5.6.2.8. Austria
- 5.6.2.9. Switzerland
- 5.6.2.10. Benelux
- 5.6.2.11. Nordic
- 5.6.2.12. Rest of Western Europe
- 6. Eastern Europe Glucagon Market Analysis, Opportunity and Forecast, 2016-2032
- 6.1. Eastern Europe Glucagon Market Analysis, 2016-2021
- 6.2. Eastern Europe Glucagon Market Opportunity and Forecast, 2023-2032
- 6.3. Eastern Europe Glucagon Market Analysis, Opportunity and Forecast, By By Route of Administration, 2016-2032
- 6.3.1. Eastern Europe Glucagon Market Analysis by By Route of Administration: Introduction
- 6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Route of Administration, 2016-2032
- 6.3.3. Injectable
- 6.3.4. Inhalation
- 6.4. Eastern Europe Glucagon Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 6.4.1. Eastern Europe Glucagon Market Analysis by By Application: Introduction
- 6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 6.4.3. Hypoglycemia
- 6.4.4. Diagnostic Aid
- 6.5. Eastern Europe Glucagon Market Analysis, Opportunity and Forecast, By By Distribution Channel, 2016-2032
- 6.5.1. Eastern Europe Glucagon Market Analysis by By Distribution Channel: Introduction
- 6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Distribution Channel, 2016-2032
- 6.5.3. Hospital Pharmacies
- 6.5.4. Drug Stores & Retail Pharmacies
- 6.5.5. Online Pharmacies
- 6.6. Eastern Europe Glucagon Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 6.6.1. Eastern Europe Glucagon Market Analysis by Country : Introduction
- 6.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 6.6.2.1. Russia
- 6.6.2.2. Poland
- 6.6.2.3. The Czech Republic
- 6.6.2.4. Greece
- 6.6.2.5. Rest of Eastern Europe
- 7. APAC Glucagon Market Analysis, Opportunity and Forecast, 2016-2032
- 7.1. APAC Glucagon Market Analysis, 2016-2021
- 7.2. APAC Glucagon Market Opportunity and Forecast, 2023-2032
- 7.3. APAC Glucagon Market Analysis, Opportunity and Forecast, By By Route of Administration, 2016-2032
- 7.3.1. APAC Glucagon Market Analysis by By Route of Administration: Introduction
- 7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Route of Administration, 2016-2032
- 7.3.3. Injectable
- 7.3.4. Inhalation
- 7.4. APAC Glucagon Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 7.4.1. APAC Glucagon Market Analysis by By Application: Introduction
- 7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 7.4.3. Hypoglycemia
- 7.4.4. Diagnostic Aid
- 7.5. APAC Glucagon Market Analysis, Opportunity and Forecast, By By Distribution Channel, 2016-2032
- 7.5.1. APAC Glucagon Market Analysis by By Distribution Channel: Introduction
- 7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Distribution Channel, 2016-2032
- 7.5.3. Hospital Pharmacies
- 7.5.4. Drug Stores & Retail Pharmacies
- 7.5.5. Online Pharmacies
- 7.6. APAC Glucagon Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 7.6.1. APAC Glucagon Market Analysis by Country : Introduction
- 7.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 7.6.2.1. China
- 7.6.2.2. Japan
- 7.6.2.3. South Korea
- 7.6.2.4. India
- 7.6.2.5. Australia & New Zeland
- 7.6.2.6. Indonesia
- 7.6.2.7. Malaysia
- 7.6.2.8. Philippines
- 7.6.2.9. Singapore
- 7.6.2.10. Thailand
- 7.6.2.11. Vietnam
- 7.6.2.12. Rest of APAC
- 8. Latin America Glucagon Market Analysis, Opportunity and Forecast, 2016-2032
- 8.1. Latin America Glucagon Market Analysis, 2016-2021
- 8.2. Latin America Glucagon Market Opportunity and Forecast, 2023-2032
- 8.3. Latin America Glucagon Market Analysis, Opportunity and Forecast, By By Route of Administration, 2016-2032
- 8.3.1. Latin America Glucagon Market Analysis by By Route of Administration: Introduction
- 8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Route of Administration, 2016-2032
- 8.3.3. Injectable
- 8.3.4. Inhalation
- 8.4. Latin America Glucagon Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 8.4.1. Latin America Glucagon Market Analysis by By Application: Introduction
- 8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 8.4.3. Hypoglycemia
- 8.4.4. Diagnostic Aid
- 8.5. Latin America Glucagon Market Analysis, Opportunity and Forecast, By By Distribution Channel, 2016-2032
- 8.5.1. Latin America Glucagon Market Analysis by By Distribution Channel: Introduction
- 8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Distribution Channel, 2016-2032
- 8.5.3. Hospital Pharmacies
- 8.5.4. Drug Stores & Retail Pharmacies
- 8.5.5. Online Pharmacies
- 8.6. Latin America Glucagon Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 8.6.1. Latin America Glucagon Market Analysis by Country : Introduction
- 8.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 8.6.2.1. Brazil
- 8.6.2.2. Colombia
- 8.6.2.3. Chile
- 8.6.2.4. Argentina
- 8.6.2.5. Costa Rica
- 8.6.2.6. Rest of Latin America
- 9. Middle East & Africa Glucagon Market Analysis, Opportunity and Forecast, 2016-2032
- 9.1. Middle East & Africa Glucagon Market Analysis, 2016-2021
- 9.2. Middle East & Africa Glucagon Market Opportunity and Forecast, 2023-2032
- 9.3. Middle East & Africa Glucagon Market Analysis, Opportunity and Forecast, By By Route of Administration, 2016-2032
- 9.3.1. Middle East & Africa Glucagon Market Analysis by By Route of Administration: Introduction
- 9.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Route of Administration, 2016-2032
- 9.3.3. Injectable
- 9.3.4. Inhalation
- 9.4. Middle East & Africa Glucagon Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 9.4.1. Middle East & Africa Glucagon Market Analysis by By Application: Introduction
- 9.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 9.4.3. Hypoglycemia
- 9.4.4. Diagnostic Aid
- 9.5. Middle East & Africa Glucagon Market Analysis, Opportunity and Forecast, By By Distribution Channel, 2016-2032
- 9.5.1. Middle East & Africa Glucagon Market Analysis by By Distribution Channel: Introduction
- 9.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Distribution Channel, 2016-2032
- 9.5.3. Hospital Pharmacies
- 9.5.4. Drug Stores & Retail Pharmacies
- 9.5.5. Online Pharmacies
- 9.6. Middle East & Africa Glucagon Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 9.6.1. Middle East & Africa Glucagon Market Analysis by Country : Introduction
- 9.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 9.6.2.1. Algeria
- 9.6.2.2. Egypt
- 9.6.2.3. Israel
- 9.6.2.4. Kuwait
- 9.6.2.5. Nigeria
- 9.6.2.6. Saudi Arabia
- 9.6.2.7. South Africa
- 9.6.2.8. Turkey
- 9.6.2.9. The UAE
- 9.6.2.10. Rest of MEA
- 10. Global Glucagon Market Analysis, Opportunity and Forecast, By Region , 2016-2032
- 10.1. Global Glucagon Market Analysis by Region : Introduction
- 10.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
- 10.2.1. North America
- 10.2.2. Western Europe
- 10.2.3. Eastern Europe
- 10.2.4. APAC
- 10.2.5. Latin America
- 10.2.6. Middle East & Africa
- 11. Global Glucagon Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 11.1. Market Share Analysis
- 11.2. Company Profiles
- 11.3. Novo Nordisk A/S (Denmark)
- 11.3.1. Company Overview
- 11.3.2. Financial Highlights
- 11.3.3. Product Portfolio
- 11.3.4. SWOT Analysis
- 11.3.5. Key Strategies and Developments
- 11.4. Fresenius SE & Co. KGaA (Germany)
- 11.4.1. Company Overview
- 11.4.2. Financial Highlights
- 11.4.3. Product Portfolio
- 11.4.4. SWOT Analysis
- 11.4.5. Key Strategies and Developments
- 11.5. Amphastar Pharmaceuticals, Inc. (U.S.)
- 11.5.1. Company Overview
- 11.5.2. Financial Highlights
- 11.5.3. Product Portfolio
- 11.5.4. SWOT Analysis
- 11.5.5. Key Strategies and Developments
- 11.6. Xeris Biopharma Holdings, Inc. (U.S.)
- 11.6.1. Company Overview
- 11.6.2. Financial Highlights
- 11.6.3. Product Portfolio
- 11.6.4. SWOT Analysis
- 11.6.5. Key Strategies and Developments
- 11.7. ILS Inc. (Japan)
- 11.7.1. Company Overview
- 11.7.2. Financial Highlights
- 11.7.3. Product Portfolio
- 11.7.4. SWOT Analysis
- 11.7.5. Key Strategies and Developments
- 11.8. (US$ Mn & Units)ed Biotech (P) Limited (India)
- 11.8.1. Company Overview
- 11.8.2. Financial Highlights
- 11.8.3. Product Portfolio
- 11.8.4. SWOT Analysis
- 11.8.5. Key Strategies and Developments
- 11.9. Zealand Pharma A/S (Denmark)
- 11.9.1. Company Overview
- 11.9.2. Financial Highlights
- 11.9.3. Product Portfolio
- 11.9.4. SWOT Analysis
- 11.9.5. Key Strategies and Developments
- 11.10. Taj Pharmaceuticals Limited (India)
- 11.10.1. Company Overview
- 11.10.2. Financial Highlights
- 11.10.3. Product Portfolio
- 11.10.4. SWOT Analysis
- 11.10.5. Key Strategies and Developments
- 11.13.1. Company Overview
- 11.13.2. Financial Highlights
- 11.13.3. Product Portfolio
- 11.13.4. SWOT Analysis
- 11.13.5. Key Strategies and Developments
- 12. Assumptions and Acronyms
- 13. Research Methodology
- 14. Contact
"
- List of Figures
- "
- Figure 1: Global Glucagon Market Revenue (US$ Mn) Market Share by By Route of Administration in 2022
- Figure 2: Global Glucagon Market Market Attractiveness Analysis by By Route of Administration, 2016-2032
- Figure 3: Global Glucagon Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 4: Global Glucagon Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 5: Global Glucagon Market Revenue (US$ Mn) Market Share by By Distribution Channelin 2022
- Figure 6: Global Glucagon Market Market Attractiveness Analysis by By Distribution Channel, 2016-2032
- Figure 7: Global Glucagon Market Revenue (US$ Mn) Market Share by Region in 2022
- Figure 8: Global Glucagon Market Market Attractiveness Analysis by Region, 2016-2032
- Figure 9: Global Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Figure 10: Global Glucagon Market Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Figure 11: Global Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Figure 12: Global Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 13: Global Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Figure 14: Global Glucagon Market Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Figure 15: Global Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Figure 16: Global Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 17: Global Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Figure 18: Global Glucagon Market Market Share Comparison by Region (2016-2032)
- Figure 19: Global Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Figure 20: Global Glucagon Market Market Share Comparison by By Application (2016-2032)
- Figure 21: Global Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Figure 22: North America Glucagon Market Revenue (US$ Mn) Market Share by By Route of Administrationin 2022
- Figure 23: North America Glucagon Market Market Attractiveness Analysis by By Route of Administration, 2016-2032
- Figure 24: North America Glucagon Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 25: North America Glucagon Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 26: North America Glucagon Market Revenue (US$ Mn) Market Share by By Distribution Channelin 2022
- Figure 27: North America Glucagon Market Market Attractiveness Analysis by By Distribution Channel, 2016-2032
- Figure 28: North America Glucagon Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 29: North America Glucagon Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 30: North America Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Figure 31: North America Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 32: North America Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Figure 33: North America Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 34: North America Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Figure 35: North America Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 36: North America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Figure 37: North America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 38: North America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Figure 39: North America Glucagon Market Market Share Comparison by Country (2016-2032)
- Figure 40: North America Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Figure 41: North America Glucagon Market Market Share Comparison by By Application (2016-2032)
- Figure 42: North America Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Figure 43: Western Europe Glucagon Market Revenue (US$ Mn) Market Share by By Route of Administrationin 2022
- Figure 44: Western Europe Glucagon Market Market Attractiveness Analysis by By Route of Administration, 2016-2032
- Figure 45: Western Europe Glucagon Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 46: Western Europe Glucagon Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 47: Western Europe Glucagon Market Revenue (US$ Mn) Market Share by By Distribution Channelin 2022
- Figure 48: Western Europe Glucagon Market Market Attractiveness Analysis by By Distribution Channel, 2016-2032
- Figure 49: Western Europe Glucagon Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 50: Western Europe Glucagon Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 51: Western Europe Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Figure 52: Western Europe Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 53: Western Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Figure 54: Western Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 55: Western Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Figure 56: Western Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 57: Western Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Figure 58: Western Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 59: Western Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Figure 60: Western Europe Glucagon Market Market Share Comparison by Country (2016-2032)
- Figure 61: Western Europe Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Figure 62: Western Europe Glucagon Market Market Share Comparison by By Application (2016-2032)
- Figure 63: Western Europe Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Figure 64: Eastern Europe Glucagon Market Revenue (US$ Mn) Market Share by By Route of Administrationin 2022
- Figure 65: Eastern Europe Glucagon Market Market Attractiveness Analysis by By Route of Administration, 2016-2032
- Figure 66: Eastern Europe Glucagon Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 67: Eastern Europe Glucagon Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 68: Eastern Europe Glucagon Market Revenue (US$ Mn) Market Share by By Distribution Channelin 2022
- Figure 69: Eastern Europe Glucagon Market Market Attractiveness Analysis by By Distribution Channel, 2016-2032
- Figure 70: Eastern Europe Glucagon Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 71: Eastern Europe Glucagon Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 72: Eastern Europe Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Figure 73: Eastern Europe Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 74: Eastern Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Figure 75: Eastern Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 76: Eastern Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Figure 77: Eastern Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 78: Eastern Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Figure 79: Eastern Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 80: Eastern Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Figure 81: Eastern Europe Glucagon Market Market Share Comparison by Country (2016-2032)
- Figure 82: Eastern Europe Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Figure 83: Eastern Europe Glucagon Market Market Share Comparison by By Application (2016-2032)
- Figure 84: Eastern Europe Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Figure 85: APAC Glucagon Market Revenue (US$ Mn) Market Share by By Route of Administrationin 2022
- Figure 86: APAC Glucagon Market Market Attractiveness Analysis by By Route of Administration, 2016-2032
- Figure 87: APAC Glucagon Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 88: APAC Glucagon Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 89: APAC Glucagon Market Revenue (US$ Mn) Market Share by By Distribution Channelin 2022
- Figure 90: APAC Glucagon Market Market Attractiveness Analysis by By Distribution Channel, 2016-2032
- Figure 91: APAC Glucagon Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 92: APAC Glucagon Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 93: APAC Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Figure 94: APAC Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 95: APAC Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Figure 96: APAC Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 97: APAC Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Figure 98: APAC Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 99: APAC Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Figure 100: APAC Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 101: APAC Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Figure 102: APAC Glucagon Market Market Share Comparison by Country (2016-2032)
- Figure 103: APAC Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Figure 104: APAC Glucagon Market Market Share Comparison by By Application (2016-2032)
- Figure 105: APAC Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Figure 106: Latin America Glucagon Market Revenue (US$ Mn) Market Share by By Route of Administrationin 2022
- Figure 107: Latin America Glucagon Market Market Attractiveness Analysis by By Route of Administration, 2016-2032
- Figure 108: Latin America Glucagon Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 109: Latin America Glucagon Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 110: Latin America Glucagon Market Revenue (US$ Mn) Market Share by By Distribution Channelin 2022
- Figure 111: Latin America Glucagon Market Market Attractiveness Analysis by By Distribution Channel, 2016-2032
- Figure 112: Latin America Glucagon Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 113: Latin America Glucagon Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 114: Latin America Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Figure 115: Latin America Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 116: Latin America Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Figure 117: Latin America Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 118: Latin America Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Figure 119: Latin America Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 120: Latin America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Figure 121: Latin America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 122: Latin America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Figure 123: Latin America Glucagon Market Market Share Comparison by Country (2016-2032)
- Figure 124: Latin America Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Figure 125: Latin America Glucagon Market Market Share Comparison by By Application (2016-2032)
- Figure 126: Latin America Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Figure 127: Middle East & Africa Glucagon Market Revenue (US$ Mn) Market Share by By Route of Administrationin 2022
- Figure 128: Middle East & Africa Glucagon Market Market Attractiveness Analysis by By Route of Administration, 2016-2032
- Figure 129: Middle East & Africa Glucagon Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 130: Middle East & Africa Glucagon Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 131: Middle East & Africa Glucagon Market Revenue (US$ Mn) Market Share by By Distribution Channelin 2022
- Figure 132: Middle East & Africa Glucagon Market Market Attractiveness Analysis by By Distribution Channel, 2016-2032
- Figure 133: Middle East & Africa Glucagon Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 134: Middle East & Africa Glucagon Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 135: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Figure 136: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 137: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Figure 138: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 139: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Figure 140: Middle East & Africa Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 141: Middle East & Africa Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Figure 142: Middle East & Africa Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 143: Middle East & Africa Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Figure 144: Middle East & Africa Glucagon Market Market Share Comparison by Country (2016-2032)
- Figure 145: Middle East & Africa Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Figure 146: Middle East & Africa Glucagon Market Market Share Comparison by By Application (2016-2032)
- Figure 147: Middle East & Africa Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
"
- List of Tables
- "
- Table 1: Global Glucagon Market Market Comparison by By Route of Administration (2016-2032)
- Table 2: Global Glucagon Market Market Comparison by By Application (2016-2032)
- Table 3: Global Glucagon Market Market Comparison by By Distribution Channel (2016-2032)
- Table 4: Global Glucagon Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 5: Global Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Table 6: Global Glucagon Market Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 7: Global Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Table 8: Global Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 9: Global Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Table 10: Global Glucagon Market Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Table 11: Global Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Table 12: Global Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 13: Global Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Table 14: Global Glucagon Market Market Share Comparison by Region (2016-2032)
- Table 15: Global Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Table 16: Global Glucagon Market Market Share Comparison by By Application (2016-2032)
- Table 17: Global Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Table 18: North America Glucagon Market Market Comparison by By Application (2016-2032)
- Table 19: North America Glucagon Market Market Comparison by By Distribution Channel (2016-2032)
- Table 20: North America Glucagon Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 21: North America Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Table 22: North America Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 23: North America Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Table 24: North America Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 25: North America Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Table 26: North America Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 27: North America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Table 28: North America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 29: North America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Table 30: North America Glucagon Market Market Share Comparison by Country (2016-2032)
- Table 31: North America Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Table 32: North America Glucagon Market Market Share Comparison by By Application (2016-2032)
- Table 33: North America Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Table 34: Western Europe Glucagon Market Market Comparison by By Route of Administration (2016-2032)
- Table 35: Western Europe Glucagon Market Market Comparison by By Application (2016-2032)
- Table 36: Western Europe Glucagon Market Market Comparison by By Distribution Channel (2016-2032)
- Table 37: Western Europe Glucagon Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 38: Western Europe Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Table 39: Western Europe Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 40: Western Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Table 41: Western Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 42: Western Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Table 43: Western Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 44: Western Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Table 45: Western Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 46: Western Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Table 47: Western Europe Glucagon Market Market Share Comparison by Country (2016-2032)
- Table 48: Western Europe Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Table 49: Western Europe Glucagon Market Market Share Comparison by By Application (2016-2032)
- Table 50: Western Europe Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Table 51: Eastern Europe Glucagon Market Market Comparison by By Route of Administration (2016-2032)
- Table 52: Eastern Europe Glucagon Market Market Comparison by By Application (2016-2032)
- Table 53: Eastern Europe Glucagon Market Market Comparison by By Distribution Channel (2016-2032)
- Table 54: Eastern Europe Glucagon Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 55: Eastern Europe Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Table 56: Eastern Europe Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 57: Eastern Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Table 58: Eastern Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 59: Eastern Europe Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Table 60: Eastern Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 61: Eastern Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Table 62: Eastern Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 63: Eastern Europe Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Table 64: Eastern Europe Glucagon Market Market Share Comparison by Country (2016-2032)
- Table 65: Eastern Europe Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Table 66: Eastern Europe Glucagon Market Market Share Comparison by By Application (2016-2032)
- Table 67: Eastern Europe Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Table 68: APAC Glucagon Market Market Comparison by By Route of Administration (2016-2032)
- Table 69: APAC Glucagon Market Market Comparison by By Application (2016-2032)
- Table 70: APAC Glucagon Market Market Comparison by By Distribution Channel (2016-2032)
- Table 71: APAC Glucagon Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 72: APAC Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Table 73: APAC Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 74: APAC Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Table 75: APAC Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 76: APAC Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Table 77: APAC Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 78: APAC Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Table 79: APAC Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 80: APAC Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Table 81: APAC Glucagon Market Market Share Comparison by Country (2016-2032)
- Table 82: APAC Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Table 83: APAC Glucagon Market Market Share Comparison by By Application (2016-2032)
- Table 84: APAC Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Table 85: Latin America Glucagon Market Market Comparison by By Route of Administration (2016-2032)
- Table 86: Latin America Glucagon Market Market Comparison by By Application (2016-2032)
- Table 87: Latin America Glucagon Market Market Comparison by By Distribution Channel (2016-2032)
- Table 88: Latin America Glucagon Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 89: Latin America Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Table 90: Latin America Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 91: Latin America Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Table 92: Latin America Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 93: Latin America Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Table 94: Latin America Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 95: Latin America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Table 96: Latin America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 97: Latin America Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Table 98: Latin America Glucagon Market Market Share Comparison by Country (2016-2032)
- Table 99: Latin America Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Table 100: Latin America Glucagon Market Market Share Comparison by By Application (2016-2032)
- Table 101: Latin America Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- Table 102: Middle East & Africa Glucagon Market Market Comparison by By Route of Administration (2016-2032)
- Table 103: Middle East & Africa Glucagon Market Market Comparison by By Application (2016-2032)
- Table 104: Middle East & Africa Glucagon Market Market Comparison by By Distribution Channel (2016-2032)
- Table 105: Middle East & Africa Glucagon Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 106: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) (2016-2032)
- Table 107: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 108: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) Comparison by By Route of Administration (2016-2032)
- Table 109: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 110: Middle East & Africa Glucagon Market Market Revenue (US$ Mn) Comparison by By Distribution Channel (2016-2032)
- Table 111: Middle East & Africa Glucagon Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 112: Middle East & Africa Glucagon Market Market Y-o-Y Growth Rate Comparison by By Route of Administration (2016-2032)
- Table 113: Middle East & Africa Glucagon Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 114: Middle East & Africa Glucagon Market Market Y-o-Y Growth Rate Comparison by By Distribution Channel (2016-2032)
- Table 115: Middle East & Africa Glucagon Market Market Share Comparison by Country (2016-2032)
- Table 116: Middle East & Africa Glucagon Market Market Share Comparison by By Route of Administration (2016-2032)
- Table 117: Middle East & Africa Glucagon Market Market Share Comparison by By Application (2016-2032)
- Table 118: Middle East & Africa Glucagon Market Market Share Comparison by By Distribution Channel (2016-2032)
- 1. Executive Summary
-
- Novo Nordisk A/S (Denmark)
- Fresenius SE & Co. KGaA (Germany)
- Amphastar Pharmaceuticals, Inc. (U.S.)
- Xeris Biopharma Holdings, Inc. (U.S.)
- ILS Inc. (Japan)
- United Biotech (P) Limited (India)
- Zealand Pharma A/S (Denmark)
- Taj Pharmaceuticals Limited (India)